Literature DB >> 16884509

Microvolt t-wave alternans with exercise in pediatrics and congenital heart disease: limitations and predictive value.

Mark E Alexander1, Frank Cecchin, Kathie P Huang, Charles I Berul.   

Abstract

BACKGROUND: Microvolt t-wave alternans (TWA) in early exercise is a noninvasive marker of life-threatening ventricular arrhythmia in some adult cardiac populations. The incidence and potential significance of sustained TWA in pediatric and congenital heart disease (CHD) populations has not been well defined.
METHODS: TWA treadmill exercise studies in pediatric patients with CHD, myopathy, potential myocardial ischemia, syncope, or history of cardiac arrest were analyzed. Tests were categorized as abnormal for sustained TWA with onset heart rate < 130 beats/min with specific analyses for lower onset heart rates. Patient characteristics were analyzed as possible correlates of TWA.
RESULTS: Over 2 years, 318 consecutive TWA exercise studies were performed in 304 patients (60% male, median 14 years, 6-41) for indications of syncope, cardiac arrest, possible ventricular arrhythmia, or evaluation of functional myocardial perfusion. Underlying conditions included apparently normal hearts (45%), CHD (16%), cardiomyopathy (11%), coronary anomalies (11%), electrical myopathy (9%), and transplant (8%). Abnormal TWA was seen in 24 (7%, onset HR 106 +/- 18) and included 19 at high clinical risk for serious events including 3 with cardiac arrest. By multivariate analysis sustained TWA was associated with cardiac arrest, ventricular arrhythmias, and a clinical classification of high risk.
CONCLUSIONS: TWA is associated with pediatric and CHD diagnoses at high risk of serious events and may contribute, with other diagnostic tools, to management choices. While the absence of TWA has relatively high negative predictive value, it does not completely exclude the potential for serious sustained ventricular arrhythmias. A more robust noninvasive marker for risk stratification in these populations is required.

Entities:  

Mesh:

Year:  2006        PMID: 16884509     DOI: 10.1111/j.1540-8159.2006.00427.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  7 in total

Review 1.  T-wave alternans: reviewing the clinical performance, understanding limitations, characterizing methodologies.

Authors:  Euler de Vilhena Garcia
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

2.  Cardiac repolarization instability during normal postnatal development.

Authors:  Salim F Idriss; Jamie A Bell
Journal:  J Electrocardiol       Date:  2008-09-19       Impact factor: 1.438

3.  Microvolt T-wave alternans during Holter monitoring in children and adolescents.

Authors:  Leonid Makarov; Vera Komoliatova
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-04       Impact factor: 1.468

Review 4.  Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology.

Authors:  Richard L Verrier; Thomas Klingenheben; Marek Malik; Nabil El-Sherif; Derek V Exner; Stefan H Hohnloser; Takanori Ikeda; Juan Pablo Martínez; Sanjiv M Narayan; Tuomo Nieminen; David S Rosenbaum
Journal:  J Am Coll Cardiol       Date:  2011-09-20       Impact factor: 24.094

Review 5.  Primary Prevention of Sudden Cardiac Death in Adults with Transposition of the Great Arteries: A Review of Implantable Cardioverter-Defibrillator Placement.

Authors:  Sandeep S Sodhi; Ari M Cedars
Journal:  Tex Heart Inst J       Date:  2015-08-01

6.  Microvolt T wave alternans in adults with congenital heart diseases characterized by right ventricle pathology or single ventricle physiology: a case control study.

Authors:  Aleksandra Cieplucha; Olga Trojnarska; Agnieszka Bartczak; Lucyna Kramer; Stefan Grajek
Journal:  BMC Cardiovasc Disord       Date:  2013-04-03       Impact factor: 2.298

7.  Increased microvolt T-wave alternans in children and adolescents with Eisenmenger syndrome.

Authors:  Derya Karpuz; Olgu Hallıoğlu; Dilek Çiçek Yılmaz
Journal:  Anatol J Cardiol       Date:  2018-04-10       Impact factor: 1.596

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.